Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
暂无分享,去创建一个
T. Sakaeda | T. Hirashima | M. Tamiya | A. Tamiya | S. Atagi | K. Nakao | S. Isa | S. Kobuchi | M. Kanazu | K. Okishio | A. Iwazaki | Shuhei Marutani | Kimie Imai | Shinji Kobuchi